Title: Founder and Scientific Director
Company: Per-Immune, Inc.
Location: Savannah, Georgia, United States
Michael George Hanna Jr., PhD, Founder and Scientific Director at Per-Immune, Inc., has been recognized by Marquis Who’s Who Top Scientists for dedication, achievements, and leadership in pathology and immunology.
The founder and scientific director of Per-Immune, Inc., since 2017, Dr. Hanna is an established pathologist and immunologist who has served myriad organizations and laboratories across the United States. The former founder, chairman and then chairman emeritus of Vaccinogen, Inc., between 2007 and 2017, he also served Organon Teknika/Biotechnology Research Institute as chief operating officer, the Litton Institute of Applied Biotechnology as director, the Frederick Cancer Research Facility of the National Cancer Institute as director, and Oak Ridge National Laboratory as director of the Immunobiology of Carcinogenesis Group, among other prominent roles. Commencing his career in 1958 as an AEC research fellow at Notre Dame University, he has accrued over 60 years of experience in his fields.
Dr. Hanna draws upon a Bachelor of Science in biology from Baldwin Wallace College, Master of Science in biology from the University of Notre Dame and Doctor of Philosophy in pathology and immunology from the University of Tennessee. He received an honorary Doctor of Science from Baldwin Wallace College in 2000. Among his notable achievements, Dr. Hanna is most renowned for achieving 14 patents in cancer, biology, and immunotherapy, as well as developing and registering TICE-BCG treatment for bladder cancer. Likewise, he developed a technology platform for Oncovax autologous tumor cell vaccines for the treatment of stage II colon cancer. Demonstrating versatility in his profession, he has also sat on the editorial board of Cancer Metastasis since 1984 and contributed to more than 225 publications.
Contact Dr. Hanna: